We use cookies to personalise the web experience for you. By using www.helgilibrary.com, you agree to our use of cookies.
Some cookies are also used by Google Analytics, which anonymously tracks visitors and helps us to analyse how users use our website. Read more

Bayer Czech Republic

Pharmaceutical > Czech Republic > Bayer Czech Republic
Change Company
Bayer Czech Republic

Bayer, s.r.o. (or Bayer Czech Republic in our case) is a Czech Republic-based subsidiary of Bayer AG, the German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. The Company is now a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. In

Read more »
Bayer, s.r.o. (or Bayer Czech Republic in our case) is a Czech Republic-based subsidiary of Bayer AG, the German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. The Company is now a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. In fiscal year 2013, Bayer employed 113,200 people and had sales of EUR 40.2 bil.

Buy all financials of Bayer Czech Republic

from $199 /month

Buy annual subscriptions for all our products.

summary Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Gross Profit CZK mil
EBIT CZK mil
Net Profit CZK mil
ROE %
EBIT Margin %
Net Margin %
Employees
                3,344 3,245 3,438 4,054 4,277    
                1.69 372 451 499 592    
                160 104 128 139 164    
                166 83.4 96.2 107 123    
                34.8% 22.3% 33.5% 40.5% 50.6%    
                4.77% 3.22% 3.72% 3.43% 3.83%    
                4.96% 2.57% 2.80% 2.64% 2.89%    
                184 170 178 181 187    

balance sheet

                774 572 698 682 830    
                70.6 30.5 17.1 15.2 16.1    
                698 539 678 662 810    
                460 289 286 243 246    
                314 283 413 440 584    
                7.97 3.22 0.000 0.000 0.000    
                306 280 410 426 522    
                -0.298 -0.098 0.140 0.150 0.890    
                -10.9% -3.80% 6.64% 8.88% 60.8%    
... ... ... ... ...     ... ... ... 11.0% 6.28% 1.76%    

cash flow

            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    

Download Data
income statement Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Cost of Goods & Services CZK mil
Gross Profit CZK mil
Staff Cost CZK mil
Other Cost CZK mil
EBITDA CZK mil
Depreciation CZK mil
EBIT CZK mil
Financing Cost CZK mil
Extraordinary Cost CZK mil
Pre-Tax Profit CZK mil
Tax CZK mil
Minorities CZK mil
Net Profit CZK mil
Dividends CZK mil
                3,344 3,245 3,438 4,054 4,277    
                3,342 2,873 2,987 3,555 3,684    
                1.69 372 451 499 592    
                250 243 277 297 324    
                -416 17.0 38.3 59.0 100    
                168 112 135 143 168    
                7.96 7.87 7.63 4.06 4.42    
                160 104 128 139 164    
                -35.4 2.33 4.94 3.72 1.58    
                0.000 0.000 0.000 0.000 0.000    
                195 102 123 135 162    
                29.1 18.6 26.7 28.3 38.7    
                0.000 0.000 0.000 0.000 0.000    
                166 83.4 96.2 107 123    
                0.000 100 150 120 60.0   ...

growth rates

...               -2.02% -2.94% 5.93% 17.9% 5.49%    
...               -158% -257% 21.4% 12.8% 19.2%    
...               -0.531% -33.0% 20.7% 5.62% 17.5%    
...               6.82% -34.6% 22.5% 8.75% 17.7%    
...               27.9% -47.7% 20.5% 10.1% 19.8%    
...               39.4% -49.7% 15.3% 11.2% 15.4%    

ratios

                34.8% 22.3% 33.5% 40.5% 50.6%    
...               170% 27.1% 26.9% 28.9% 29.0%    
                0.050% 11.5% 13.1% 12.3% 13.8%    
                5.01% 3.46% 3.94% 3.53% 3.93%    
                4.77% 3.22% 3.72% 3.43% 3.83%    
                4.96% 2.57% 2.80% 2.64% 2.89%    
                0.000% 120% 156% 112% 48.6%   ...
... ... ... ... ...     ... ... ... 11.0% 6.28% 1.76%    
                -0.298 -0.098 0.140 0.150 0.890    

Download Data
balance sheet Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

balance sheet

                70.6 30.5 17.1 15.2 16.1    
                24.1 20.0 16.7 14.7 15.1    
                3.24 1.05 0.395 0.504 1.01    
                698 539 678 662 810    
                145 193 185 230 263    
                264 268 356 357 403    
                50.0 11.0 71.2 6.99 0.936    
                774 572 698 682 830    
                460 289 286 243 246    
                0.000 0.000 0.000 0.000 0.000    
                314 283 413 440 584    
                7.97 3.22 0.000 0.000 0.000    
                0.000 0.000 0.000 0.000 0.000    
                0.000 0.000 0.000 0.000 0.000    
                306 280 410 426 522    
                0.000 0.000 90.1 28.5 151    
                210 146 188 230 204    
                3.92 0.000 0.000 12.1 61.9    
                774 572 698 682 830    

growth rates

...               -41.7% -26.0% 22.0% -2.28% 21.7%    
...               -6.69% -37.1% -1.31% -15.1% 1.44%    
...               -71.1% -78.0% -272% 13.5% 595%    
... ... ... ... ... ...   ... ... ... ... -68.3% 428%    

ratios

                0.000 0.000 90.1 28.5 151    
                -50.0 -11.0 19.0 21.5 150    
                199 315 353 356 463    
                270 345 371 371 479    
                -10.9% -3.80% 6.64% 8.88% 60.8%    
... ... ... ... ...     ... ... ... 11.0% 6.28% 1.76%    

Download Data
cash flow Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

cash flow

                166 83.4 96.2 107 123    
                7.96 7.87 7.63 4.06 4.42    
...           ... ... ... ... ... ... ...    
...           ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
... ... ... ... ... ... ... ... ... ... ... ... ...    
...           ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    
            ... ... ... ... ... ... ...    

ratios

                28.8 30.2 37.8 32.1 34.4    
                15.8 24.6 22.6 23.6 26.1    
                22.9 18.6 23.0 23.7 20.2    
                21.7 36.1 37.5 32.0 40.3    
                174 91.3 104 111 128    
            ... ... ... ... ... ... ...    

Download Data
other data Unit
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

other data

                15.8% 12.4% 15.1% 15.5% 16.3%    
                0.050% 11.5% 13.1% 12.3% 13.8%    
                184 170 178 181 187    
                6,399 6,086 6,633 6,393 6,044    
                113,170 119,036 129,773 136,628 144,259    
                7.85% 7.73% 8.37% 7.58% 7.87%    
                14.9% 18.2% 21.7% 20.9% 23.8%    
                2,475 2,444 2,503 3,017 3,242    
            ... ... ... ... ... ... ...    
                17.0 24.0 23.2 1,037 1,034    
                0.508% 0.740% 0.673% 25.6% 24.2%    

Download Data
Comparison of 9 Companies in Czech Pharmaceutical Companies

This Annual Statistical Dossier offers a comparison of 9 companies from Czech Pharmaceutical Companies from 2000 to 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

The file

Read more »

This Annual Statistical Dossier offers a comparison of 9 companies from Czech Pharmaceutical Companies from 2000 to 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

The file contains data of following companies:

If you are only interested in particular areas of the company's business, you can find and download specific indicators from the company's Corporate Profile, or specific charts from the company's Chart Section.

Download a sample excel file attached to see more details. On purchase, the hidden cells will be unlocked and all available data wll be visible.

Bayer Czech Republic in Numbers

This Annual Statistical Dossier offers a summary of Bayer Czech Republic's performance between 2003 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you are only interested

Read more »

This Annual Statistical Dossier offers a summary of Bayer Czech Republic's performance between 2003 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you are only interested in particular areas of the company's business, you can find and download specific indicators from the company's Corporate Profile, or specific charts from the company's Chart Section.

If you are interested in the company’s quarterly figures, please refer to the company’s Quarterly Statistical Dossier.

Bayer Czech Republic at a Glance

Bayer, s.r.o. (or Bayer Czech Republic in our case) is a Czech Republic-based subsidiary of Bayer AG, the German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. The Company is now a global enterprise with core competencies in

Read more »

Bayer, s.r.o. (or Bayer Czech Republic in our case) is a Czech Republic-based subsidiary of Bayer AG, the German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. The Company is now a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. In fiscal year 2013, Bayer employed 113,200 people and had sales of EUR 40.2 bil.

This report offers a summary of the company's performance in 2003-2012. You will find here all the key numbers from the company's balance sheet, income statement and cash flow on the annual, in the local currency as well as in USD

Bayer Czech Republic in Numbers

Bayer, s.r.o. (or Bayer Czech Republic in our case) is a Czech Republic-based subsidiary of Bayer AG, the German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. The Company is now a global enterprise with core competencies in

Read more »

Bayer, s.r.o. (or Bayer Czech Republic in our case) is a Czech Republic-based subsidiary of Bayer AG, the German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. The Company is now a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. In fiscal year 2013, Bayer employed 113,200 people and had sales of EUR 40.2 bil.

This excel file offers a summary of the company's performance in 2003-2012. You will find here all the key numbers from the company's balance sheet, income statement and cash flow on the annual, in the local currency as well as in USD

Bayer Czech Republic made a net profit of CZK 106 mil in 2017, down 39.4% when compared to the last year. Total sales reached CZK 4,180 mil, which is down 3.37% when compared to the previous year.

Historically, the company’s

Read more »

Bayer Czech Republic made a net profit of CZK 106 mil in 2017, down 39.4% when compared to the last year. Total sales reached CZK 4,180 mil, which is down 3.37% when compared to the previous year.

Historically, the company’s net profit reached an all time high of CZK 175 mil in 2016 and an all time low of CZK -11.8 mil in 2007.

In terms of sales, Bayer Czech Republic reached an all time high of CZK 4,326 mil in 2016 and an all time low of CZK 637 mil in 2007.

Bayer Czech Republic's net profit has grown 4.89% a year on average in the last five years while sales have increased by 5.19% a year since 2012.

The firm generated its shareholders an average return on invested capital of 23.7% in the last five years.

As far as Bayer Czech Republic's peers are concerned, Amgen Czech Republic posted a net profit and sales of CZK 37.8 mil and CZK 417 mil in 2017.

You can see all the company’s data at Bayer Czech Republic Profile, or you can download a report on the company in the report section.

Bayer Czech Republic made a net profit of CZK CZK 106 mil under revenues of CZK 4,180 mil in 2017, down 39.4% and -3.37%, respectively, when compared to the last year.

This translates into a net margin of 2.53%. Historically,

Read more »

Bayer Czech Republic made a net profit of CZK CZK 106 mil under revenues of CZK 4,180 mil in 2017, down 39.4% and -3.37%, respectively, when compared to the last year.

This translates into a net margin of 2.53%. Historically, the firm’s net margin reached an all time high of 10.8% in 2003 and an all time low of -1.86% in 2007. The average net margin in the last five years amounted to 2.98%.

On the operating level, EBITDA margin reached 3.62% and EBIT amounted to 3.77% of sales in 2017.

As far as Bayer Czech Republic's peers are concerned, Amgen Czech Republic posted net and EBITDA margin of 9.06% and 11.8%, respectively in 2017.

You can see all the company’s data at Bayer Czech Republic Profile, or you can download a report on the company in the report section.

Bayer Czech Republic made a net profit of CZK 106 mil under revenues of CZK 4,180 mil in 2017, down -39.4% and -3.37%, respectively, when compared to the last year. This translates into a net margin of 2.53%.

Historically, the

Read more »

Bayer Czech Republic made a net profit of CZK 106 mil under revenues of CZK 4,180 mil in 2017, down -39.4% and -3.37%, respectively, when compared to the last year. This translates into a net margin of 2.53%.

Historically, the firm’s net profit reached an all time high of CZK 175 mil in 2016 and an all time low of CZK -11.8 mil in 2007. Since 2012, the firm's net profit has increased 26.9% or 4.89% a year on average.

On the operating level, EBITDA reached CZK 158 mil, up -32.3% when compared to the previous year. Over the last five years, company's EBITDA has grown 7.04% a year on average.

As far as Bayer Czech Republic's peers are concerned, Amgen Czech Republic posted net and EBITDA margin of 9.06% and 11.8%, respectively in 2017.

You can see all the company’s data at Bayer Czech Republic Profile, or you can download a report on the company in the report section.

Bayer Czech Republic's net debt reached CZK 393 mil and accounted for 94.4% of equity at the end of 2017. The ratio is down 26.2% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all

Read more »

Bayer Czech Republic's net debt reached CZK 393 mil and accounted for 94.4% of equity at the end of 2017. The ratio is down 26.2% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 128% in 2016 and an all time low of -37.2% in 2008.

When compared to EBITDA, net debt amounted to 2.49x at the end of the year. The ratio reached an all time high of 9.61 in 2007 and an all time low of -1.03 in 2010.

As far as Bayer Czech Republic's peers are concerned, Amgen Czech Republic posted net debt to equity of -0.147%x and -0.006x when compared to EBITDA at the end of 2017..

You can see all the company’s data at Bayer Czech Republic Profile, or you can download a report on the company in the report section.

See all charts of the company »
Bayer CR's net profit fell 39.4% to CZK 106 mil in 2017
Bayer CR's net profit fell 39.4% to CZK 106 mil in 2017
Bayer CR's employees rose 1.65% to 185 in 2017
Bayer CR's Total Cash From Operations rose 149% to CZK 122 mil in 2017
Bayer CR's Capital Expenditures fell 25.2% to CZK 3.68 mil in 2017
Bayer CR's Net Debt/EBITDA rose 25.9% to 2.49 in 2017
Bayer CR's Cash & Cash Equivalents rose 94.1% to CZK 10.8 mil in 2017
Bayer CR's ROCE fell 54.9% to 10.4% in 2017
Bayer CR's Net Margin fell 37.3% to 2.53% in 2017